IL33 and psoriasis: Chen et al. found that patients with moderate–severe psoriasis have both sera- and intra-epidermal levels of Il-33 higher than healthy controls and, in the same study, an Imiquimod induced Pso model in experimental mice was ameliorated by the injection of IL-33, suggesting the possible anti-inflammatory role of this cytokine [21].